Your email has been successfully added to our mailing list.

×
0.00254452926208657 0.00508905852417303 0.00508905852417303 0.0038167938931298 0.00386768447837153 0.00699745547073788 0.00510178117048344 0.020356234096692
Stock impact report

U.S. FDA approves Biogen’s Alzheimer’s drug, sending its shares soaring [Toronto Globe and Mail (Ontario, Canada)]

AC Immune SA (ACIU)  More Company Research Source: Toronto Globe and Mail
Last ac immune sa earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acimmune.com/en/investors
PDF U.S. FDA approves Biogen’s Alzheimer’s drug, sending its shares soaring A vial and packaging for the drug Aduhelm on June 7, 2021. The Associated Press A vial and packaging for the drug Aduhelm on June 7, 2021. U.S. regulators on Monday approved Biogen Inc’s aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease, sending its shares soaring, despite controversy over whether the clinical evidence proves the drug works. Biogen said it has priced the drug, to be sold as Aduhelm, at $56,000 per year. Its shares jumped nearly 52 per cent to $434.52 when trading resumed following the approval. U.S. traded shares of partner Eisai Co were already up $33.50, or 45 per cent, to $107.75 Aducanumab aims to remove sticky deposits of a protein called amyloid beta from the brains of patients in earlier stages of Alzheimer’s in order to stave off its ravages, which include memory loss and the inability to care for one’s self. “This is good news for patients with Alzheimer [Read more]
Impact snapshot Event time: ACIU
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ACIU alerts

from News Quantified
Opt-in for
ACIU alerts

from News Quantified